Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Colinz Laboratories Ltd

NSE: COLINZ · BSE: 531210 · Pharmaceuticals & Biotechnology · 24 announcements

Share price
₹71.80
Market cap
₹18.09 Cr
Revenue (annual)
₹6.14 Cr
Net profit (annual)
₹0.51 Cr
P/E (TTM)
6.5×Sector 47.4×
Promoter holding
50.60%-15.40% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

13:22 IST BSE
Acquisition

Colinz Laboratories Acquisition

Mr. Padam Dugar and PACs acquired a 15.01% stake in Colinz Laboratories through an off-market transaction. This significant non-promoter entry impacts the company's shareholding structure.